ATE551999T1 - P-glycoprotein-hemmer mit octiloniumbromid als wirkstoff - Google Patents

P-glycoprotein-hemmer mit octiloniumbromid als wirkstoff

Info

Publication number
ATE551999T1
ATE551999T1 AT03741600T AT03741600T ATE551999T1 AT E551999 T1 ATE551999 T1 AT E551999T1 AT 03741600 T AT03741600 T AT 03741600T AT 03741600 T AT03741600 T AT 03741600T AT E551999 T1 ATE551999 T1 AT E551999T1
Authority
AT
Austria
Prior art keywords
bromide
glycoprotein inhibitor
octilonium
active ingredient
drugs
Prior art date
Application number
AT03741600T
Other languages
English (en)
Inventor
Hesson Chung
Seo-Young Jeong
Ick-Chan Kwon
Yeong-Taek Park
In-Hyun Lee
Soon-Hong Yuk
Original Assignee
Daehwa Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daehwa Pharm Co Ltd filed Critical Daehwa Pharm Co Ltd
Application granted granted Critical
Publication of ATE551999T1 publication Critical patent/ATE551999T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03741600T 2002-07-20 2003-07-21 P-glycoprotein-hemmer mit octiloniumbromid als wirkstoff ATE551999T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2002-0042794A KR100503889B1 (ko) 2002-07-20 2002-07-20 옥틸로늄 브로마이드를 함유하는 항암제 흡수 증진제
PCT/KR2003/001441 WO2004009073A1 (en) 2002-07-20 2003-07-21 P-glycoprotein inhibitor comprising octilonium bromide as an effective ingredient

Publications (1)

Publication Number Publication Date
ATE551999T1 true ATE551999T1 (de) 2012-04-15

Family

ID=36611883

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03741600T ATE551999T1 (de) 2002-07-20 2003-07-21 P-glycoprotein-hemmer mit octiloniumbromid als wirkstoff

Country Status (6)

Country Link
US (2) US20060141033A1 (de)
EP (1) EP1545495B1 (de)
KR (1) KR100503889B1 (de)
AT (1) ATE551999T1 (de)
AU (1) AU2003281468A1 (de)
WO (1) WO2004009073A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005032228A1 (ja) 2003-09-26 2005-04-07 Sony Computer Entertainment Inc. 携帯型電子装置
EP2496217B1 (de) * 2009-08-24 2019-03-27 Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi Direktverpressung von otilonium
EP2582375A4 (de) * 2010-06-16 2013-12-25 Embera Neurotherapeutics Inc Zusammensetzungen und verfahren zur behandlung von sucht, psychischen störungen und neurodegenerativen erkrankungen
WO2018165649A1 (en) 2017-03-10 2018-09-13 Embera Neurotherapeutics, Inc. Pharmaceutical compositions and uses thereof
JP2020526537A (ja) 2017-07-14 2020-08-31 ユニバーシティ オブ マサチューセッツ 炎症を処置するための方法および組成物
CA3110250A1 (en) 2018-08-22 2020-02-27 Bacainn Therapeutics, Ltd. Cyclosporine compositions and methods of use
KR102203334B1 (ko) * 2019-04-12 2021-01-15 성균관대학교산학협력단 피모자이드의 항암제 병용요법
CN114377003B (zh) * 2020-10-16 2023-09-15 中国科学院上海药物研究所 奥替溴铵在抗肿瘤中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1216283B (it) * 1986-11-04 1990-02-22 Menarini Sas Utilizzazione di ottilonio bromuro (dci) per applicazione topica nel tratto gastro-intestinale e relativa formulazione farmaceutica appropriata per tale uso.
US5968972A (en) * 1995-10-26 1999-10-19 Baker Norton Pharmaceuticals, Inc. Method for increasing the oral bioactivity of pharmaceutical agents
DE69700887T2 (de) * 1996-01-31 2000-06-29 Nisshin Flour Milling Co., Ltd. Isoprenderivate
GB9717576D0 (en) * 1997-08-19 1997-10-22 Xenova Ltd Pharmaceutical compounds
GB9721352D0 (en) * 1997-10-08 1997-12-10 Medinnova Sf Resistance modifying agent
KR20020013174A (ko) * 2000-08-11 2002-02-20 민경윤 경구 흡수율이 낮은 약물의 흡수율을 증가시키기 위한경구용 조성물
WO2003082199A2 (en) * 2002-03-27 2003-10-09 Massachusetts Institute Of Technology Platelet-activating factor antagonists as analgesic, anti-inflammatory, uterine contraction inhibiting, and anti-tumor agents

Also Published As

Publication number Publication date
EP1545495B1 (de) 2012-04-04
EP1545495A1 (de) 2005-06-29
AU2003281468A1 (en) 2004-02-09
EP1545495A4 (de) 2007-01-24
WO2004009073A1 (en) 2004-01-29
US20060141033A1 (en) 2006-06-29
KR20040009018A (ko) 2004-01-31
US20100029755A1 (en) 2010-02-04
KR100503889B1 (ko) 2005-07-26

Similar Documents

Publication Publication Date Title
BRPI0417717A (pt) composto, composição farmacêutica, e, uso de um composto
CY1111797T1 (el) Τοπικη φαρμακοτεχνικη μορφη ιβερμεκτινης για την θεραπεια δερματολογικων καταστασεων
NO20080068L (no) Topisk unguale formuleringer
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
NO20083630L (no) Nye pyridinderivater
ATE467413T1 (de) Oxindolderivate als antikrebsmittel
SE0301653D0 (sv) Novel compounds
MXPA05012463A (es) Combinaciones farmaceuticas de un inhibidor de bomba protonica y un compuesto que modifica la motilidad gastrointestinal.
PT1506185E (pt) Compostos novos e sua utilizacao
DE602007014036D1 (de) 12-aryl-prostaglandin-analoga
DK1511489T3 (da) Nye farmaceutiske sammensætninger indeholdende flibanserin-polymorf A
WO2005117895A8 (en) Compositions comprising meloxicam
EA200600953A1 (ru) Дозированные формы торсемида пролонгированного высвобождения
ATE551999T1 (de) P-glycoprotein-hemmer mit octiloniumbromid als wirkstoff
EA201101119A1 (ru) Дозируемая форма, содержащая пантопразол в качестве активного ингредиента
MXPA06011467A (es) Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid).
DK1814848T3 (da) 2,3,4-substitueret-cyclopentanoner som terapeutiske midler
BRPI0417265A (pt) composição farmacêutica compreendendo um princìpio ativo e sulfobetaìna
EA200501565A1 (ru) Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса
UY29069A1 (es) Uso de compuestos tpo miméticos y composiciones farmacéuticas para el tratamiento de la anemia
NO20064783L (no) Opplosningstabeletter med licarbazepin
UY27628A1 (es) "2'-halo -3',5'-dialcoxi-fen-1'il-2-imidazolidinas y su uso como un fármaco"
EA200602156A1 (ru) Новая комбинация ингибитора iтока синусового узла и кальциевого ингибитора и фармацевтические композиции, её содержащие
PA8646301A1 (es) Inhibidores de la adenilato ciclasa soluble
ATE460934T1 (de) Pharmazeutische zubereitungen von ciprofloxacin